Shopping Cart 0
Cart Subtotal
AED 0

T2 Biosystems Inc (TTOO) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company's T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company's products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

T2 Biosystems Inc (TTOO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

T2 Biosystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

T2 Biosystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

T2 Biosystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

T2 Biosystems Inc, Medical Equipment, Deal Details 11

Venture Financing 11

T2 Biosystems Raises USD 40 Million In Series E Financing 11

Partnerships 13

T2 Biosystems Enters into Agreement with Allergan 13

T2 Biosystems Enters into R&D Agreement with Bayer 14

T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 15

Equity Offering 16

T2 Biosystems Raises USD52.6 Public Offering of Shares 16

T2 Biosystems Raises USD20 Million in Public Offering of Shares 18

T2 Biosystems Raises USD40 Million in Private Placement of Shares 20

T2 Biosystems Raises USD34 Million in Public Offering of Shares 21

T2 Biosystems Raises USD65.7 Million in IPO 23

T2 Biosystems Inc-Key Competitors 25

T2 Biosystems Inc-Key Employees 26

T2 Biosystems Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Financial Announcements 28

Aug 02, 2018: T2 Biosystems reports second quarter 2018 financial results and provides corporate update 28

May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 29

Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update 30

Nov 02, 2017: T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update 32

Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 34

May 02, 2017: T2 Biosystems Reports First Quarter 2017 Results and Corporate Update 35

Feb 13, 2017: T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results 37

Jan 09, 2017: T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress 39

Corporate Communications 40

Feb 05, 2018: T2 Biosystems Names John Sprague As CFO 40

May 01, 2017: T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer 41

Product News 42

Nov 09, 2017: T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 42

Aug 30, 2017: T2 Biosystems Announces 11 New Patents Granted in 2017 43

Jun 07, 2017: T2 Biosystems Announces New T2Sepsis Solution Clinical and Economic Results Presented by Leading Experts at ASM Microbe 2017 Conference 44

Jan 25, 2017: T2 Biosystems to Host Webinar on the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship 45

Other Significant Developments 46

Jan 04, 2018: T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel 46

Aug 15, 2017: T2 Biosystems and Aridis Pharmaceuticals Join Antimicrobials Working Group 47

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

T2 Biosystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

T2 Biosystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

T2 Biosystems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

T2 Biosystems Inc, Medical Equipment, Key Facts, 2017 2

T2 Biosystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

T2 Biosystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

T2 Biosystems Inc, Deals By Market, 2012 to YTD 2018 9

T2 Biosystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

T2 Biosystems Raises USD 40 Million In Series E Financing 11

T2 Biosystems Enters into Agreement with Allergan 13

T2 Biosystems Enters into R&D Agreement with Bayer 14

T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 15

T2 Biosystems Raises USD52.6 Public Offering of Shares 16

T2 Biosystems Raises USD20 Million in Public Offering of Shares 18

T2 Biosystems Raises USD40 Million in Private Placement of Shares 20

T2 Biosystems Raises USD34 Million in Public Offering of Shares 21

T2 Biosystems Raises USD65.7 Million in IPO 23

T2 Biosystems Inc, Key Competitors 25

T2 Biosystems Inc, Key Employees 26

T2 Biosystems Inc, Other Locations 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

T2 Biosystems Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company's T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company's products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

T2 Biosystems Inc (TTOO)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

T2 Biosystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

T2 Biosystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

T2 Biosystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

T2 Biosystems Inc, Medical Equipment, Deal Details 11

Venture Financing 11

T2 Biosystems Raises USD 40 Million In Series E Financing 11

Partnerships 13

T2 Biosystems Enters into Agreement with Allergan 13

T2 Biosystems Enters into R&D Agreement with Bayer 14

T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 15

Equity Offering 16

T2 Biosystems Raises USD52.6 Public Offering of Shares 16

T2 Biosystems Raises USD20 Million in Public Offering of Shares 18

T2 Biosystems Raises USD40 Million in Private Placement of Shares 20

T2 Biosystems Raises USD34 Million in Public Offering of Shares 21

T2 Biosystems Raises USD65.7 Million in IPO 23

T2 Biosystems Inc-Key Competitors 25

T2 Biosystems Inc-Key Employees 26

T2 Biosystems Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Financial Announcements 28

Aug 02, 2018: T2 Biosystems reports second quarter 2018 financial results and provides corporate update 28

May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 29

Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update 30

Nov 02, 2017: T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update 32

Aug 03, 2017: T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update 34

May 02, 2017: T2 Biosystems Reports First Quarter 2017 Results and Corporate Update 35

Feb 13, 2017: T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results 37

Jan 09, 2017: T2 Biosystems Reports Preliminary Fourth Quarter Results and Operational Progress 39

Corporate Communications 40

Feb 05, 2018: T2 Biosystems Names John Sprague As CFO 40

May 01, 2017: T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer 41

Product News 42

Nov 09, 2017: T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 42

Aug 30, 2017: T2 Biosystems Announces 11 New Patents Granted in 2017 43

Jun 07, 2017: T2 Biosystems Announces New T2Sepsis Solution Clinical and Economic Results Presented by Leading Experts at ASM Microbe 2017 Conference 44

Jan 25, 2017: T2 Biosystems to Host Webinar on the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship 45

Other Significant Developments 46

Jan 04, 2018: T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel 46

Aug 15, 2017: T2 Biosystems and Aridis Pharmaceuticals Join Antimicrobials Working Group 47

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48


List Of Figure

List of Figures

T2 Biosystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

T2 Biosystems Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

T2 Biosystems Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

T2 Biosystems Inc, Medical Equipment, Key Facts, 2017 2

T2 Biosystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

T2 Biosystems Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

T2 Biosystems Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

T2 Biosystems Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

T2 Biosystems Inc, Deals By Market, 2012 to YTD 2018 9

T2 Biosystems Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

T2 Biosystems Raises USD 40 Million In Series E Financing 11

T2 Biosystems Enters into Agreement with Allergan 13

T2 Biosystems Enters into R&D Agreement with Bayer 14

T2 Biosystems Enters into Co-Development Agreement with Canon U.S. Life Sciences 15

T2 Biosystems Raises USD52.6 Public Offering of Shares 16

T2 Biosystems Raises USD20 Million in Public Offering of Shares 18

T2 Biosystems Raises USD40 Million in Private Placement of Shares 20

T2 Biosystems Raises USD34 Million in Public Offering of Shares 21

T2 Biosystems Raises USD65.7 Million in IPO 23

T2 Biosystems Inc, Key Competitors 25

T2 Biosystems Inc, Key Employees 26

T2 Biosystems Inc, Other Locations 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

T2 Biosystems Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat